Brain metabolite changes in patients with type 2 diabetes and cerebral infarction using proton magnetic resonance spectroscopy

International Journal of Neuroscience

Volumn 124, Issue 1, 2014, Pages 37-41

  Zhang, Min ^a   Sun, Xinhai ^b   Zhang, Zhengjun ^b   Meng, Qiang ^b   Wang, Yuzhong ^b   Chen, Jing ^b   Ma, Xueqin ^a   Geng, Houfa ^b   Sun, Lin ^b  

^a SHANDONG UNIVERSITY   (China)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral infarction; Diabetes; Lac; NAA

Indexed keywords

CHOLINE; CREATINE; GLUCOSE; HEMOGLOBIN A1C; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BASAL GANGLION; BRAIN INFARCTION; BRAIN METABOLISM; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLITE; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETER;

AGED; ASPARTIC ACID; BLOOD GLUCOSE; BRAIN; CEREBRAL INFARCTION; CHOLINE; CREATINE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LACTIC ACID; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS;

EID: 84890107725     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.816958     Document Type: Article

References (25)

1. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998;29(12):2491-500
2. Tuomilehto J, Rastenyte D, Jousilahti P, et al. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke 1996; 27(2):210-5
3. Megherbi SE, Milan C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3months after stroke: Data from the European BIOMED Stroke Project. Stroke 2003; 34(3):688-94
4. Luchsinger JA, Tang MX, Stern Y, et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001;154(7):635-41
5. Alkan, A, Kutlu R, Hallac T, et al. Occupational prolonged organic solvent exposure in shoemakers: Brain MR spectroscopy findings. Magn Reson Imaging 2004;22(5):707-13
6. Alkan A, Kutlu R, Kocak G, et al. Brain MR spectroscopy in children with a history of rheumatic fever with special emphasis on neuropsychiatric complications. Eur J Radiol. 2004;49(3):224-8
7. Alkan A, Sarac K, Kutlu R, et al. Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1. Magn Reson Imaging 2003; 21(9):1049-53
8. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539-53
9. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21(4):637-76
10. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: Histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20(9):1619-27
11. Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12(6):435-52
12. Frahm J, Bruhn H, Gyngell ML, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites.Magn Reson Med 1989;11(1):47-63
13. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4(2):47-52
14. Higuchi T, Fernandez EJ, Maudsley AA, et al. Mapping of lactate and N-acetyl-L-aspartate predicts infarction during acute focal ischemia: In vivo 1H magnetic resonance spectroscopy in rats. Neurosurgery 1996;38(1):121-9; discussion 129-30
15. ParsonsMW, Li T, Barber PA, et al. Combined(1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000;55(4):498-505
16. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: Detection with proton MR spectroscopy. Radiology 1992;184(1):123-30
17. Sarac K, Akinci A, Alkan A, et al. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 2005;47(7):562-5
18. Yip PK, He YY, Hsu CY, et al. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 1991;41(6):899-905
19. Prado R, Ginsberg MD, Dietrich WD, et al. Hyperglycemia increases infarct size in collaterally perfused but not endarterial vascular territories. J Cereb Blood Flow Metab 1988;8(2):186-92
20. Vincent AM, Brownlee M, Russell JW.Oxidative stress and programmed cell death in diabetic neuropathy. Ann NY Acad Sci 2002; 959:368-83
21. Kumar JS, Menon VP. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993;42(11):1435-9
22. Kario K, Matsuo T, Hoshide S, et al. Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study. Stroke 1999;30(5):1033-7
23. Goldberg MP, Ransom BR. New light on white matter. Stroke 2003;34(2):330-2
24. Graham GD, Kalvach P, Blamire AM, et al. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26(2):225-9
25. Gideon P, Henriksen O, Sperling B, et al. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke 1992;23(11):1566-72